FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum

Clinical trial NCT06393816 · RECRUITING

Trial details

NCT number: NCT06393816
Sponsor: Centre Leon Berard
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Large Cell Neuroendocrine Carcinoma of the Lung

Start date: 2024-06-13
Primary completion: 2028-09-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.